Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Evolus Inc (NQ: EOLS ) 16.62 -0.01 (-0.06%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Evolus Inc < Previous 1 2 3 Next > A Closer Look at 5 Analyst Recommendations For Evolus October 03, 2024 Via Benzinga Analyst Scoreboard: 4 Ratings For Evolus September 13, 2024 Via Benzinga EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q2 2024 July 31, 2024 EOLS stock results show that Evolus missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early July 31, 2024 The company reported $1.1 million in adjusted operating income, well ahead of expectations for a $2.6 million loss. Via Investor's Business Daily Evolus: Chiseling Away At The Aesthetic Market May 25, 2024 Via Talk Markets EOLS Stock Earnings: Evolus Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 EOLS stock results show that Evolus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday May 02, 2024 Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday! Via InvestorPlace Recap: Evolus Q4 Earnings March 07, 2024 Via Benzinga Earnings Outlook For Evolus March 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session March 21, 2024 Via Benzinga EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q4 2023 March 07, 2024 EOLS stock results show that Evolus missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings February 01, 2024 Novo Nordisk ADR sees its Relative Strength Rating move into the elite 90-plus level. Via Investor's Business Daily Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 29, 2024 Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... Via Benzinga Earnings Preview: Evolus August 01, 2023 Via Benzinga 5 Analysts Have This to Say About Evolus July 28, 2023 Via Benzinga Earnings Scheduled For March 7, 2024 March 07, 2024 Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. Via Benzinga AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating February 14, 2024 A Relative Strength Rating upgrade for AbbVie shows improving technical performance. Via Investor's Business Daily SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday January 29, 2024 U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported... Via Benzinga Topics Stocks Exposures US Equities Evolus Set For Promising 2024: Analysts Maintain Positive Outlook On Botox Alternative Maker January 17, 2024 Evolus beats Q4 revenue expectations, up 40% YoY at $61M. Full-year 2023 hits $202M, exceeding guidance. Analysts bullish on Evolus. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 17, 2024 Via Benzinga Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition January 11, 2024 AbbVie Inc's (NYSE: ABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing... Via Benzinga Exposures Product Safety Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings December 12, 2023 Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to... Via Benzinga Exposures Product Safety Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 08, 2023 Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. Via Benzinga Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday November 08, 2023 U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 08, 2023 Via Benzinga Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket November 08, 2023 Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session November 07, 2023 Via Benzinga 7 Must-Own Small-Cap Stocks That Could Outperform the Market October 08, 2023 If you’re ready to absorb significant risk for the chance of ridiculous upside, these small-cap stocks to buy may be just for you. Via InvestorPlace 7 Small-Cap Stocks Analysts Predict Will Double in 2024 September 13, 2023 While small-cap stocks to buy present exceptional risk, they also offer tremendous rewards for intrepid retail investors. Via InvestorPlace Over $15M Bet On Impinj? Check Out These 4 Stocks Insiders Are Buying August 16, 2023 Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.